Search results for "expansion"

Daewoong Pharmaceutical’s Nabota Hits 1 Trillion Won in Cumulative Sales 12 Years Post-Launch

Daewoong Pharmaceutical’s Nabota Hits 1 Trillion Won in Cumulative Sales 12 Years Post-Launch

Daewoong Pharmaceutical announced on the 13th that its flagship botulinum toxin product, Nabota, surpassed 1 trillion won in cumulative sales as of...
Dismissed as 'Old Age': The Silent Heart Condition Catching Seniors Off Guard

Dismissed as 'Old Age': The Silent Heart Condition Catching Seniors Off Guard

In late June, a man in his late 70s suddenly collapsed while checking his rice paddies after finishing spring planting and routine fieldwork.
Pregnancy Triggers Breast Immune Cells That May Help Suppress Cancer, Study Finds

Pregnancy Triggers Breast Immune Cells That May Help Suppress Cancer, Study Finds

While women who have gone through pregnancy and childbirth are known to carry a lower long-term risk of developing...
Japanese Medical Scholars Visit Daegu, Praising South Korea's Advanced Healthcare and Rich Cultural Heritage

Japanese Medical Scholars Visit Daegu, Praising South Korea's Advanced Healthcare and Rich Cultural Heritage

South Korea’s advanced medical infrastructure and deep cultural heritage left a lasting impression on prominent figures...
GC Biopharma to Conduct Phase 3 Clinical Trial for Two-Dose Chickenpox Vaccine in South Korea

GC Biopharma to Conduct Phase 3 Clinical Trial for Two-Dose Chickenpox Vaccine in South Korea

GC Biopharma’s chickenpox vaccine, Barycela Inj., is set to enter a Phase 3 clinical trial in South Korea to confirm...
Daewoong Pharmaceutical Secures 145.2 Billion Won MENA Export Deal for Diabetes Drug Enblo

Daewoong Pharmaceutical Secures 145.2 Billion Won MENA Export Deal for Diabetes Drug Enblo

Daewoong Pharmaceutical’s proprietary type 2 diabetes treatment, Enblo (active ingredient: enavogliflozin), is set to...
Qurient’s Mocaciclib Opens New Combination Frontiers for Hard-to-Treat Breast Cancer

Qurient’s Mocaciclib Opens New Combination Frontiers for Hard-to-Treat Breast Cancer

Qurient announced on June 29 that it presented key clinical data highlighting the mechanistic advantages of its...
Target the Core: Why 'Deep Remission' Is the New Gold Standard in Inflammatory Bowel Disease Treatment

Target the Core: Why 'Deep Remission' Is the New Gold Standard in Inflammatory Bowel Disease Treatment

Treatment for inflammatory bowel disease is rapidly moving beyond simple symptom management toward the structural...
The Silent Threat: Why Older Male Smokers Need Abdominal Aortic Aneurysm Screening

The Silent Threat: Why Older Male Smokers Need Abdominal Aortic Aneurysm Screening

Persistent pain in the abdomen, lower back, or flank—or an uncomfortable sensation of fullness—should never be brushed...
Medytox’s Neuramis Clinches China Approval, Paving Way for Dermal Filler Market Entry

Medytox’s Neuramis Clinches China Approval, Paving Way for Dermal Filler Market Entry

Medytox announced on the 25th that China’s National Medical Products Administration has granted product approval for...